Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the treatment of these gastric ulcers with one of the three following treatment groups: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; or ranitidine 150 mg twice daily.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
400
20mg Oral tablet once daily
150mg oral twice daily
40mg oral tablet once daily
To assess the safety and efficacy of esomeprazole 40 mg qd versus ranitidine 150 mg bid through 8 weeks of treatment for the healing of gastric ulcers in patients receiving daily NSAID therapy. Healing is defined as the absence of gastric ulcers.
Patient and investigator assessed GI symptoms for up to 8 weeks of treatment.
Time frame: Assessments at week 0, week 4 and week 8
Safety and tolerability of the treatments for 8 weeks of treatment.
Time frame: Assessments at week 0, week 4 and week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.